Segments - Net Sales and Adjusted EBITDA of Reportable Segments (Detail) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Segment Reporting Information [Line Items]
Net sales		$ 1,716.6	$ 1,746.2	$ 5,034.2	$ 5,277.6
Adjusted EBITDA Margin		17.70%	17.20%	16.90%	16.90%
Non-U.S. GAAP Total Company Adjusted EBITDA		$ 303.9	$ 300.0	$ 852.6	$ 891.8
Operating Segments [Member] | Food Care [Member]
Segment Reporting Information [Line Items]
Net sales		814.6	836.4	2,381.6	2,562.8
Adjusted EBITDA		$ 172.5	$ 168.4	$ 483.1	$ 532.6
Adjusted EBITDA Margin		21.20%	20.10%	20.30%	20.80%
Operating Segments [Member] | Diversey Care [Member]
Segment Reporting Information [Line Items]
Net sales		$ 497.4	$ 501.8	$ 1,470.7	$ 1,504.7
Adjusted EBITDA		$ 64.6	$ 66.4	$ 187.1	$ 176.5
Adjusted EBITDA Margin		13.00%	13.20%	12.70%	11.70%
Operating Segments [Member] | Product Care [Member]
Segment Reporting Information [Line Items]
Net sales	[1]	$ 388.6	$ 389.3	$ 1,130.0	$ 1,153.1
Adjusted EBITDA	[1]	$ 88.2	$ 81.9	$ 244.1	$ 237.9
Adjusted EBITDA Margin		22.70%	21.00%	21.60%	20.60%
Other [Member]
Segment Reporting Information [Line Items]
Net sales	[1]	$ 16.0	$ 18.7	$ 51.9	$ 57.0
Adjusted EBITDA	[1]	$ (21.4)	$ (16.7)	$ (61.7)	$ (55.2)
Product Concentration Risk [Member] | Net Sales [Member] | Operating Segments [Member] | Food Care [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage		47.50%	47.90%	47.30%	48.60%
Product Concentration Risk [Member] | Net Sales [Member] | Operating Segments [Member] | Diversey Care [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage		29.00%	28.70%	29.20%	28.50%
Product Concentration Risk [Member] | Net Sales [Member] | Operating Segments [Member] | Product Care [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage		22.60%	22.30%	22.40%	21.80%

[1] As of January 1, 2016, our Kevothermal business was moved from Other to our Product Care Segment. This resulted in a reclassification of $4.6 million of net sales and $0.9 million of adjusted EBITDA for the three months ended September 30, 2015 and $10.3 million of net sales and $2.3 million of adjusted EBITDA for the nine months ended September 30, 2015.